CohBar, Inc. (NASDAQ:CWBR – Get Free Report) shares dropped 8.9% on Thursday . The stock traded as low as $0.31 and last traded at $0.41. Approximately 1,174 shares traded hands during trading, a decline of 60% from the average daily volume of 2,958 shares. The stock had previously closed at $0.45.
CohBar Price Performance
The stock’s 50 day simple moving average is $0.50 and its 200-day simple moving average is $0.46.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Recommended Stories
- Five stocks we like better than CohBar
- Health Care Stocks Explained: Why You Might Want to Invest
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Insider Trading – What You Need to Know
- Nebius Group: The Rising Star in AI Infrastructure
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20221024070415&h=45&w=95&zc=2){kind=logo}
